Detalles de la búsqueda
1.
Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor.
Eur J Drug Metab Pharmacokinet
; 47(1): 91-103, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716565
2.
Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study.
Eur J Drug Metab Pharmacokinet
; 43(2): 239-249, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29076028
3.
Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics.
Clin Drug Investig
; 38(8): 737-750, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846887
4.
Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies.
Clin Transl Sci
; 11(6): 616-623, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30136756
Resultados
1 -
4
de 4
1
Próxima >
>>